Transatlantique Private Wealth LLC Catalent, Inc. Transaction History

Transatlantique Private Wealth LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$32.18 - $46.57 $6,854 - $9,919	213 Added 1.73%	12,521 $562,000
Q3 2023 Jun 25, 2024	BUY	$44.2 - $50.2 $544,013 - $617,861	12,308 New	12,308 $560,000
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $6,806 - $7,730	154 Added 1.27%	12,308 $549,000
Q2 2023 Jun 25, 2024	SELL	$31.86 - $67.26 $29,629 - $62,551	-930 Reduced 7.11%	12,154 $526,000
Q2 2023 Aug 10, 2023	SELL	$31.86 - $67.26 $29,629 - $62,551	-930 Reduced 7.11%	12,154 $527,000
Q1 2023 Jun 25, 2024	BUY	$45.44 - $74.26 $594,536 - $971,617	13,084 New	13,084 $859,000
Q1 2023 May 05, 2023	BUY	$45.44 - $74.26 $50,074 - $81,834	1,102 Added 9.2%	13,084 $839,000
Q4 2022 Jun 25, 2024	BUY	$41.39 - $81.0 $495,934 - $970,542	11,982 New	11,982 $539,000
Q4 2022 Feb 06, 2023	BUY	$41.39 - $81.0 $264,813 - $518,238	6,398 Added 114.58%	11,982 $531,000
Q3 2022 Nov 04, 2022	BUY	$72.36 - $113.1 $2,098 - $3,279	29 Added 0.52%	5,584 $404,000
Q2 2022 Aug 01, 2022	BUY	$87.2 - $114.05 $484,396 - $633,547	5,555 New	5,555 $596,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Transatlantique Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Transatlantique Private Wealth LLC with notifications on news.